Skip to main content
Premium Trial:

Request an Annual Quote

ReachBio to Distribute Axiogenesis Cell Analysis Products in North America

NEW YORK (GenomeWeb News) – Seattle-based ReachBio today said that it would distribute Axiogenesis' full product line to the North American life science research and drug discovery markets.
Cologne-based Axiogenesis sells tissue-specific cells derived from specially engineered mouse stem cell lines that are used in basic research, drug discovery, and toxicity testing of new drug candidates. According to a ReachBio statement, the first cell types available from Axiogenesis are pure atrial cardiomyocytes used for cardiotoxicity screening, electrophysiology studies, and as a cellular model system for hypertrophic cardiomyopathy.
Heribert Bohlen, CEO of Axiogenesis, said in a statement that ReachBio “share[s] our philosophy that cellular model systems for drug discovery and toxicity testing should utilize highly relevant cells that are as close to the natural state as possible. The biopharma industry is trying to find ways to move away from the use of artificial cell lines that have questionable biological significance in the drug development process, and towards more biologically relevant cellular systems.”
Terms of the agreement were not disclosed.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.